01801.HK
Innovent Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 102.40
−0.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 62.25x
- P/E 2027E
- 38.95x
- P/E 2028E
- 28.83x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 63.70x
- PEG TTM
- —
- Price / book
- 3.85x
- Price / sales
- 2.95x
- Price / cash flow
- 6.88x
Enterprise value
- Enterprise value
- HKD 72.4B
- EV / sales
- 2.30x
- EV / EBITDA
- 18.89x
- EV / EBIT
- 23.88x
- Market cap
- HKD 93.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026